Head-to-head · Value Score
HealthRX vs Ro
Two GLP-1 deals, scored on the same six factors. HealthRX lands a Value Score of 86, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
HealthRX
#11 · Grade A- · Great Deal
Est. first month
$190/mo
Save ~86% vs brand-nameRo
#153 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
HealthRX takes it on Value Score, 86 to 74 — an est. $190/mo first month, with no teaser step-up baked in. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | HealthRX | Ro |
|---|---|---|
| Value Score | 86 (A-) | 74 (C+) |
| Est. first month | $190/mo | Not disclosed |
| Save vs brand-name | ~86% | — |
| Semaglutide | $190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188) | Not disclosed |
| Tirzepatide | $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148) | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | Not publicly listed | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
HealthRX
A LegitScript-certified, physician-supervised program that's one of the few offering a genuine oral GLP-1 tablet alongside injectable — with transparent flat monthly pricing and no insurance required.
Why it's a deal
- LegitScript-certified (#50087439) — a genuine third-party trust signal
- Physician-supervised telehealth with licensed-provider intake
- Both molecules plus a rare oral GLP-1 tablet for the needle-averse
- Transparent flat monthly pricing with no insurance required
The fine print
- Compounded medication is not FDA-approved
- Some pricing tiers are company-stated and the site is thin — confirm before you buy
- Brand-name tiers are an expensive pass-through (Ozempic ~$1,299/mo)
- States served are not publicly listed — confirm coverage before you sign up
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores HealthRX is ranked on the HealthRX alternatives ranking, and the same list for the other side is on alternatives to Ro.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.